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ABSTRACT
This study investigated the effect of ibuprofen on
soreness and performance of a muscle suffering delayed
onset muscle soreness (DOMS). The subjects in this
study were college aged women (n=19), randomly assigned
to receive either ibuprofen or a placebo. DOMS was
induced on one 1eg through a series of eccentric
reciprocal exercises for the hamstring and quadricep
muscle groups on a Kin-Com, isokinetic exercise testing
machine. Strength measurements were taken before and
for four days after soreness inducted for bot.h the
exercised and unexercised 1eg. In addition to the
strengt.h measures, subjects completed pain and
perception of performance scales. The data were
analyzed using 2 x 5 (group x day) ANOVA with repeated
measures on the second factor to examine strength
differences. Interpretation of significant findings
indicated that the subjects experienced DOMS, however
there was no indication that the therapeutic
administration of ibuprofen prevented decrements in
performance secondary to soreness. Inspection of a
significant day effect (p . . 05) revealed that pain was
significant on days 2 and 3 for both groups when
t.he subjects' responses to the perception of
performance and pain scales in relationship to actual
performance. A moderate negative correlation for pain
scale responses existed, however, therapeutic ibuprofen
did not attenuate pain. The reporting differences in
the pain scale responses indicates that pain may be a
better indicator of change in performance than the
perception of performance sca1e. These data il-Iustrate
that the daily therapeutic administration of 800 mg of
ibuprofen does not reduce pain nor at.Lenuate the
decrease in performance that tlpical1y accompanies
DOMS. However, pain response as measured by the pain
scale in the present. study, may be a good indicator of
changes in performance capacity during DOMS.
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Chapter 1
INTRODUCTION
Delayed onset muscle soreness (OOIAS) is
experienced by most people after a novel and strenuous
muscular task. The symptoms are pain or soreness and
muscle weakness (Francis & Hoobler, 1988). Although
much research has been conducted, there is 1itt1e known
about thd specific etiology of DOMS. Several theories
have been presented with the most accepted being the
muscle tissue damage theory. Research also indicates
that the most predictable way to produce soreness is
through eccentric muscle contractions (Hasson, Dani-e1s,
Divine, Niebuhr, Rj-chmond & Wil.liams, 1993) . Most.
types of physical act.ivity require eccentric work and
rel-atively mild activities, such as walking or running,
may cause DOMS for some individuals.
Treatment for DOMS is as much of a mystery as the
etiology. Predominant treat.ments in the 1ay community
include ice, heat, massage, and the use of liniments.
However, these treatments have only provided limited
and temporary relief. Other forms of t.reatment, such
as preexercise training and non-steroidal anti-
inflammatory drugs (NSAIDs), have.been studied with
2each having limited success. There is no single
treatment known to effect.ively decrease both the muscle
soreness and muscle weakness experienced with DOMS.
One assumption made about soreness is that when it
is present t.here will- be a subsequent decrement in
contractile performance. There have been very few
studies that actually address various treat.ment.s with
ability to perform after encountering DOMS. Most
research to date has aided in the understanding of the
symptoms and possible causes of DOMS. This study will
investigate the role ibuprofen, a NSAID, plays in the
perception of pain and the ability to perform when an
individual is suffering with DOMS.
Statement of Problem
Considering that DOMS is a common occurrence and
little is known about how to treat it, this study
investigated the effects of ibuprofen on performance
and perceptions of muscle soreness and performance
capacity in the hamstring and quadricep muscle groups
after eccentric contractions that have elicited DOMS.
Maior Hvpotheses
The nu11 hytrlotheses for this study are: l-)
ibuprofen wil-I have no effect on eccentric and
3j-sometric performance of the sore muscle groups for the
exercised and nonexercised l"g; 2) ibuprofen will- have
no effect on the amount of soreness perceived for the
exercised or nonexercised 1"9; 3) ibuprofen will- have
no effect on the subject's perception of performance
for the exercised or nonexercised groups under
eccentric or isometric conditions; 4) ibuprofen will
have no effect on the relationship between the
perception of performance and the actual performance
for exercised and nonexercised groups under eccentric
or isometric condit.ions.
Minor Hlpotheses
The following are the minor nuII hypot.heses for
each major hypothesis in t.his st.udy:
l-) There is no significant difference between the
treatment and control groups in eccentric hamst.ring
performance over five days for the exercised leg. 2)
There is no significant difference between the
treatment and control groups in eccentric hamstring
performance over five days for the nonexercised feg.
3) There is no significant difference between the
treatment and control groups in eccentric quadricep
performance over five days for the exercised Ieg. 4)
1
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There is no significant difference between the
treat.ment and control groups in eccentric quadricep
performance over five days for the unexercised 1eg. 5)
There is no significant difference between the
treatment and control groups in isometric hamstring
performance for the exercised 1eg. 6) There is no
significant difference between the treatment and
control- groups in isometric hamstring performance for
the unexercised Ieg. 7) There is no significant
difference between the treatment and control groups in 
r
Iisometric quadricep performance over five days for the iI
exercised 1eg. 8) There is no significant difference
between the treaLment and cont.rol groups in isometric
quadricep performance over five days for the
unexercised 1eg.
9) There is no significant difference between the
amount of pain reported on the pai-n scale between the
treatment and control groups for the exercised leg.
10) There is no significant difference between the
amount of pain reported on the pain scale between the
treatment and control groups for the nonexercised feg.
11) There is no significant difference between the
treatment and contro1 group in the perception of the
5subjects abtt■ity o perform eccentrttc work with the
exercttsed ■eg。  ■2)There is nO significant difference         l
between the treatment and control group in the
percepttton of the subjects′ ability to perform
j
eccentric work wttth the nonexercised leg。  ■3)There is        l
no sign■ficant difference between the treatment and
control group in the perception of performance ■n the
isometric work for the exercttsed leg over four days.
■4)There is no significant difference between the
treatment and control group in the percepttton of               f
performance in the lsometric work for the nonexercised         l
:leg over four days.  ■5)There is nO correlation
between the subjects′perc ption of performance and
the■r actual performance for the exerc■sed and
ill[I:r:i:[isiegi6i°h::[hilalitili:e]::i:la::li[:ntthe        l
subjects′ pain responses and their actual performance
for the exerc■sed and nonexerc■sed legs fo  both
hamstr■ng and quadr■cep muscle groups.
Assumptttons of studv
For the purpose of this study′ the following
assumptions were made ■n the prelttm■nary stages of
■nvestigation:
"‐輩
61. The pain rating scale was an accurate means
for measuring the soreness experienced and each subject
reported pain accurately and honestly.
2. The perception of performance scale was an
accurate means of interpreting the subjects' subjective
feelings of their own performance and each subject
understood the questions on t.he perception scale and
answered honest.ly.
3. The subjects were representative of typical
college age females.
4. Ibuprofen is a safe and effbctive ant.i-
inflammatory and analgesic medication that may
affect the physiological event.s surrounding DOMS.
5. When muscles become sore it is directly
related to an injury process relat.ed t.o the type of
contracLion used for movemenL.
Delimitations
The delimitations of this st.udy are as follows:
1. College-aged female students from fthaca
College were the subjects.
2. Only eccentric exercises of the hamstrings and
quadriceps were performed to induce muscle soreness.
3. only the ef fect.s of ibuprofen were
7investigated.
4. Only eccentric and isometric muscle
contraction strength of the hamstrings and quadriceps
were measured as est.imates of muscular performance.
5. Pain and perception scales, and an isokinetic
machine were used as measurement tooIs.
Limit.ations
The limitations of this study are as follows:
1. The resul-ts may only be generalized to
college-aged females.
2. The results may only hold true when these
subject.ive pain and perception scal-es are used.
3. The results may only apply to eccentrically
induced muscle pain.
4. The result may only apply to the use of the
NSAID ibuprofen.
5. The results may only apply to isokinetic
eccentric strength measurements of the hamstrings and
quadriceps.
Definition of Terms
The following terms were operationally defined for
the purpose of t.his investigation:
1. Dynamic exercise - muscle activity in which
I
the joint involved is moving t.hrough a range of motion.
2. Control group - those subject.s who received a
placebo in place of ibuprofen.
3. Treatment group - those subjects who received
ibuprofen.
4. Active range of motion - the available range
through which the subject is able to move.
5. Eccentric reciprocal exercises - eccentric
hamstring contraction followed by an eccentric
quadricep contraction through the 
"-r"ilrbl" range of
motion.
6. Muscle strengt.h - the amounL of force a muscle
is able to produce, also known as peak torque.
Chapter 2
REVIEW OF LITERATURE
The review of literature for this study focused on
the following areas: (a) definition and prevalence of
DOMS, (b) possible etiologies of DOMS, (c) pain
mechanisms of DOMS, (d) DOMS and performance, (e) DOMS
and training, (f) treatment of DOMS, and (g) summary.
Definition and Prevalence of DOMS
DOMS is the sensation of discomfort or pain in
skeletal muscle that often occurs after participation
in an unaccusLomed muscular activity (Trifflet.ti,
Litchfield, Clarkson, & Byrnes, 1988) . This pain or
soreness may appear hours or days l-at.er. DOMS has been
experienced by most individuals, however its symptoms
of muscl-e soreness and weakness are tolerated because
the pain is transient and no effective treatment is
known (Donnel1y, McCormick, Maughan, Whiting, &
Cl-arkson, l-988) . Soreness usually increases in
intensity during the 24 hours following exercise, peaks
about 48 hours postexercise and then subsides so that
by 5 to 7 days after exercise it has disappeared
(Armstrong, 1984 ) .
DOMS is unpleasanL and at times it may be
debilit,at.ing (Schwane, Wi11iams, & S1oan, 1-987) . The
perception of soreness may vary from slight stiffness
that subsides rapidly with routine daily activities to
severe pain that interferes with movement (Armstrong,
1,984). The affected muscles are usually firm and
tender, and the force they are able Lo generate during
maximal voluntary contractions or when stimulated
electrically is drastically decreased. The soreness is
also exacerbated if exLreme pressure is exerted on the
affected muscle or if these muscles are exercised. In
the l-atter case, however, the soreness quickly
diminishes if the exercise is continued for more than a
few minutes. In fact, it has been indicated that the
most effective way to provi-de relief of the sore
muscles is to exercise them (Clarkson, Byrnes,
Gillisson, & Harper, 1987) .
Any skeletal muscle that. is overexerted may suffer
DOMS. For e:iamp1e, following prolonged downhill
running subjects in one st.udy experience soreness and
pain in all of the major extensors of t.he hips, thighs,
and legs (Schwane et dI., 1987). Tenderness is often
localized in the distal portion of the muscle in the
region of the muscle-tendon junction. One theory
■0
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suggests that muscle pain receptors are most
concentrated in the region of the tendons and
connective tissue. Another theory suggests that
localizat.ion of soreness may occur because the angle of
the fibers to the long axis of the muscles is greatest
in this region, thus increasing the susceptibility of
the fibers to mechanical t.rauma (Armstrong, l-984) .
These theories not wit.hstanding, in cases of severe
DOMS the pain is generalized t.hroughout most of the
muscle bel1y (Byrnes & Clarkson, 1985).
DOMS is well accepted as a temporary discomfort.
and t.hose who experience the syndrome do not. usually
seek medical attention. Lack of medical attention
leaves the clinical dat.a on the prevalence of this form
of muscular pain incomplete (Armstrong, 1984).
However, nearly every healthy adult has experienced
DOMS, most probably on numerous occasions.
Possible Etioloqies of DOMS
The degree of DOMS experienced is related to both
the intensity of muscle contraction and its duration.
It is bel-ieved that intensity is the more important
determinant of the two factors. There are stiII some
inconsistencies evident when considering which factors
1-2
associated with muscle force production are responsible
for t.he symptoms experienced with DOMS. Several-
hypotheses have been proposed that could be associated
with the decrease in muscular function, including: (1)
increased tension in the contractile and elastic
components of the muscle fibers t.hat cause physical
damage to the structural elements (Francis & Hoobler,
L987) , (2) increased metabolism that results in t.he
accumulation of waste products (Francis, 1983), (3)
altered neural control of the muscle, producing spasms
that elicit pain (Armstrong, L984; Byrnes & Clarkson,
1985), and (4) increased muscl-e temperature that causes
structural damage (Armstrong, 1984) . Most of the
evidence accumul-ated to date supports the first theory,
however, each theory has some merit and will be
discussed in detail.
The most predictable way t,o produce DOMS is to
have muscles perform eccentric contractions (Berry,
Moritani, & Tolson, 1990) . Exercises involving
eccentric contractions result in greater muscle
soreness than those with concentric contractions.
Any form of exercise that primarily involves
eccentric exercise will produce greater delayed
1_3
sor'eness than equivalent. concentric contractions (".g.,
downhill running versus uphiI1 running). During level
locomotion, runningL dr watking, and jumping, the
greatest amount of tension in the extensor muscles is
produced during the eccentric contraction phase of the
activity. It seems plausible that participation in
athletic activity resulting in DOMS is a specific
response to the eccentric component of that activity.
Structural Damaqe Theory
Structural damage from high t.ension is a theory
that was first. offered in the early 1900's, the
investigator reported that DOMS was not related to the
state of fatigue of the muscle (Armstrong, 1984) . The
greatest acute fatigue and discomfort resulted in the
least amount of soreness after exercise and it was
concluded from that there are two di-stinct types of
muscle pain associated with exercise. The first type
of pain is that which occurs during exercise and the
second type is that pain which occurs after exercise
(i.e., DOMS) .
Since the damage hypothesis was first proposed,
ultrasound, radiology, and biopsy have been utilized to
show that muscle damage actually occurs (Bobbert.,
L4
Hollander, & Huijing, 1985). Measurement of serum
creatine kinase (SCK) , drr enz).me marker of muscl_e
damage (Triffletti et dI., 1988), and magnetic
resonance imaging (MRI) have been used to investigat,e
the extent of muscle damage (Fleckenstein, Weatheral,
Parkey, Payne, & Peshock, 1989). Studies in animal
and humans have shown that despite the low energy cost
of eccentric muscle contractions, they cause more
profound changes in muscle structure and function than
concentric contractions (O'ReiIly, Warhol, Fielding,
Frontera, Meredith, & Evans, L987) . In an eccentric
contraction fewer motor units are recruited than in a
concentric contracLion while the same amount of force
is produced. Thus, in an eccentric contraction the
force is distributed over a smaller cross-sectional
area of the muscle, meaning t.he tension per active
cross-secti-onaI area is greater (Berry et dI., 1990) .
It seems logical that this in'crease in tension per
motor unit area could cause mechanical disruption of
the structural elements in the muscle fibers
themselves. .One, study has concl-uded that eccentric
exercises are generally associated with disruption of
the muscle fiber connective sheath, primarily at muscl-e
15
tendon junct.ions, and possible damage to the myofibrils
(Hasson, Barnes, Hunter, & Wil1iams, 1989). This
tissue damage is followed by an infl-ammatory response
(Francis, 1983) and by celluIar infil-tration of
lymphocytes and granulocyte which may cause pain.
Unfortunately, it. is still unknown exactly how damaged
muscle tissue results in the perception of pain.
Although several studies have indicated that
structuraf damage occurs in the muscle, it has not been
shown that. injury to muscle cells or connective tissue
is a causative f actor in DOMS (Trif f Iett.i et dl. ,
1988).
Metabolic Theorv
The most popular concept explaining DOMS in the
Iay community is t.he met.abolic waste accumufation
t.heory. The relationship between exercise intensity
and the extent of soreness continues to be the primary
logic in this theory. During exercise metabolic
impairment causes fiber necrosis and subsequent
degeneration and regeneration of the muscle fibers.
This response to exercise is similar to the
degeneration/regeneration process that is observed
after two to three hours of ischemia. This response is
1,6
only temporary (Armstrong, L984).
There are considerable data t.hat. argue against the
metabolic hypothesis. The most convincing evidence is
that eccentric muscl-e contractions cause'the greatest
amount of soreness but require less energy expenditure
than concentric contractions (Byrnes & Clarkson, 1985) .
Exercise invol-vingr eccentric contractions requires
lower oxygen consumption and produces less lactat.e t.han
concentric contractions of equal power output (Schwane
et d1., 1-987). For exampfe, the metabolic hypothesis
was tested by having subjects run downhill and Ieve1 at
the same speed and duration on two separate occasions.
The downhill running required significantly l-ess oxygen
consumption, produced less lactic acid, and resul-ted in
greater delayed soreness than did leve1 running
(Armst.rong, 1984 ) .
Musc1e Spasm Theory
The muscle spasm theory contends that muscle pain
initiates a positive feedback response that leads to
tonic local muscular spasms, which in turn causes more
Ioca1 pain. According to t.his hypothesis, spasm
results in pain through loca1 ischemia of the muscle,
which may be caused by compression of the blood vessels
t7
wit.hin the muscle. Also hypothesized is that. the
magnitude of the pain is dependent upon the number of
motor units that are involved (Bobbert et df ., l-gBG) .
Several st.udies have been conducted ut.ilizing the
electromyogram (EMG) t.o determine the electrical or
tonic activity of the sore muscles. These studies have
found that. there is an increase in elect.rical activity
in sore muscles. In one study (Berry et dI., l-990),
eccentric and concentric contractions were compared for
changes in electrical activity. The results of the
study indicated that aft.er eccentric contractions there
is an increase in el-ectrical activity. This increased
electrical activity- is thought t.o be necessary in order
to produce f orce compat ible t.o t.hat produced prior to
exercise and the onset of soreness. There was no
change in the EMG of the concentrically contracted
muscles. Unfortunat.ely in this study and others, the
increased electrical- activity was not directly
associated with increases in muscle pain (Armstrong,
L984; Berry et dI., 1990).
Muscle Temperature Theory
Increased muscle temperature has also been
considered as a possible cause of DOMS. Temperature
18
increases may be related to t.he inflammatory process
that. is bel-ieved to be triggered by muscle damage
(Bobbert et d1., 1985). Eccentric exercise may
generate higher 1oca1 temperatures within the muscles
than concentric contractions (Berry et dl., 1990).
Elevated temperatures within the muscle due t.o
eccentric exercise or inflammation could conceivably
cause structural damage in the muscle resulting in
necrosis of muscle and breakdown of connective tissue.
Another possibility is t.hat type III and IV afferent.
nerve endings are sensitive to temperatures of 38" to
4Bo C. These two fiber types are responsible for
carrying noxious st.imuli to the brain and may be
negatively affected by an elevation in loca1
temperature.
One possibl.e explanation for the delay in the
onset of muscle soreness may be the infl-ammatory
response. The inf l-ammatory process j-nvolves t.he
release and accumulation of chemicals and the format.ion
of edema. The time required for t.hese changes to take
place may explain the lapse between the incidence of
muscle damage and the onset of soreness perception
(Bobbert et dI., 1985).
l_9
In summary, although each of these theories has
merit, each has its drawbacks. Not enough is known
about. the etiology of DOMS. The structural- tissue
damage theory is generally accept,ed as the most
appropriate explanatj-on of DOMS (Armstrong, 1984) .
However, the tissue damage theory in conjunction with
the inflammation theory may be the most complete
explanation of DOMS (Hasson et dI., 1989).
Pain Mechanisms of DOMS
The first and foremosL indication that muscle
damage has occurred is that the muscle has a diminished
capacity to perform work. Associated with muscle
damage is the perception of pain, however, muscle
damage itself wiII not always result in pain (Byrnes &
Clarkson, 1985). There are numerous myopathies in
which muscle damage is evident without any pain. When
a myopathy is found to be painful it is associated with
a rapid destruction of muscle tissue. Evidence exists
that exercise which results in soreness is associated
with a rapid destruction of muscle tissue.
Byrnes and Cl-arkson (1985) have suggested that
acutely damaged ce11s provide the sensation of pain by
the production of noxious stimuli. Edema products of
20
the inflammatory response, the release of endogenous
chemicals, or a combination of these may serve as the
noxious agents. Free nerve endings around the muscl_e
fibers are considered the receptors for the stimuli.
Specific afferent neurons are responsible for carrying
pain messages to t.he consc j-ous level (Hasson et dI. ,
l-989) . These afferent neurons are groups III and IV
and they respond to chemical and mechanical changes
within the muscle.
DOMS and Performance
A clear relationship between the amount, of
soreness and the amount of t.issue damage has been
demonstrated, as well as a hypothesized relat.ionship
bet.ween t.he amount of soreness and it' s af f ect on
muscle function. This second relationship is not well
understood because it has been demonstrated t.hat
muscular activity decreases the amount of soreness
within that muscle. Thus t.he question is raised as to
whether or not a decrement in performance will be
measurable. One study indicat.ed that a decrease in
strength lasting a week or longer is associated with
DOMS. Because this exercise-induced damage is not
perceived as pain until 24 to 48 hours aft.er exercise,
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a person may be unaware that damagre is occurring and
may continue to exercise causing more severe damage
(Dedrick & Clarkson, 1989) . In this study, subjects
were generally unable to detect their strength
deficits.
Another study suggested that when eccentric
exercise causes soreness there is also a delayed repair
of the ultrastructural damage and impaired repletion of
muscfe glycogen (O'Rei11y et dI., 1987). This delayed
repair process may also inhibit normal funct,ion or
cause a decrement in performance.
DOMS and Traininq
It is well known to most exercise enthusiasts that
DOMS only follows the first. few days of a new exercise
program. This experience leads to t.he common belief
that training will prevent or reduce future muscl-e
damage and soreness (Byrnes & Clarkson, 1985) . There
have been several studies that have investigated t.he
effect. of training in alleviating future soreness.
The training effect on DOMS appears to be
specific, not only for the particular muscl-es involved,
but for the type of exercise (i.e., concent.ric or
eccentrj-c) (Armstrong, 1984) . One study has shown that
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a single bout of an eccentric exercise produces
significantly larger SCK elevation than a bout seven
days later. Another study reported t.hat a single bout
of downhill running had a preventive effect on the
subsequent development of DOMS and increased SCK level
(Clarkson et df. , l9B7) . Diminished SCK release is an
indicator that training decreases the amount of muscl-e
injury occurring (Clarkson et dI., 1987; Clarkson &
Tremblay, 1988). Thus, soreness experienced following
eccentric exercise is reduced by'training that includes
eccentric contractions. One study indicated that
concentric training does not. adequately train nor
protect those muscle fibers that are used in eccentiic
contractions of the same motion (Sforzo & Lamb, 1985).
The muscular changes that occur with training and which
prevent DOMS are not known at the present, t,ime.
One explanation for this training phenomenon is
that a bout of unaccustomed exercise will damage a
specific pool of stress-susceptible muscle fibers,
resulting in a large SCK response. It has been
suggested that t.hese fragile muscle fibers may develop
through disuse. Subsequently, the dynamic process of
degeneration/regeneration will result in fewer stress-
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suscept.ible fibers when the work bout is repeated
(Byrnes & Clarkson, 1985). Ultrastructure observation
of muscl-e after eccentric and exhaustive exercise
supports t.his concept.
Treatment of DOMS
As stated earlier, DOMS is believed to be
associated with muscle fiber damage and there is
evidence t.hat an inflammat.ory type response also occurs
(Donne11y et dI., l-988) . In addition, swelling usually
occurs 24 to 48 hours postexercise and is thought t.o
contribute to the irritation of nerve endings resulting
in additional discomfort and' soreness. It is well-
known that histamine, bradykinin, and prostaglandins
contribute to the inflammatory response in ischemic
tissue damage.
NSAIDs have been studied to determine their
possible effects on DOMS. NSAIDs bind to plasma
proteins and inhibit prostaglandin synthesis or release
(Stanit.ski, 1,987 ) and are thought to decrease the
perception of muscle soreness. Two st.udies of
particular conseguence indicated that aspirin (Francis
& Hoobler, ]-987 ) and dicl-ofenac (Donnelly et dI., 1988)
are effective in mediating the sympt.oms of DOMS to some
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degree. These anti-inflammatory agent.s do not improve
performance nor do they alter t.he amount. of chemical
indices of muscle damage present. Additionally, one
study investigated aspJ-rin's effect on recovery from
soreness (ttorin & Clarkson, 1990) . This study
concluded that treatment with aspirin appeared to
attenuate muscle soreness and it did not diminish the
recovery of strength. In fact, a trend for faster.
recovery was seen with the aspirin treatment group.
Recent studies with animals and exercise-induced muscle
damage have indicated that the degenerative process in
the muscles may not foll-ow the normal inflammatory
sequence. This deviation in the inflammatory process
may explaj-n the lack of improvement in muscle funct.ion
despite the improvement in soreness with a NSAID
treatment (Francis & Hoobler, 1987).
A preliminary investigation into the effects of
ibuprofen was conducted by Hasson et aI. (1993). This
study concluded that. ibuprofen taken prophylactically
can reduce DOMS which is at.t.ributed to a decrease in
inflammatory process, specifically the release of
prostaglandins. Ibuprofen administered therapeutically
demonstrated marked decreases in DOMS and performance
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J-mprovement at 48 hours af t.er exercise. Conversely, a
similar study found that neither t.he prophylactic nor
the placebo group demonstrated a greater deficiency J_n
performance (Grossman, Arnold, Perrin and Kahler, 1995)
Another study demonstrated that transcutaneous
elect.rical nerve st.imulation (rnuS) is successful in
decreasing the amount of pain perceived. TENS,
however, did not demonstrate an anti-inflammatory
effect as was expected by the investigators (Denegar,
Perrin, Rogo1, & Rutt, 1989). The use of high velocity
resistance exercise has also been studied as a
therapeutic modality for dealing with muscle soreness.
The use of concentric contractions at submaximal levels
does not produce tissue damage and thus does not el-icit
an inflammatory response. In addition, concentric
contractions are associated with much lower intra-
muscular pressure and muscle edema, possibly due to the
"muscle pumping actionrr associated with this type of.
rhythmical contraction (Hasson et dI., 1989). This
study indicated that high speed contractions were very
effective in decreasing DOMS and facilitating return to
nornial muscle performance. The proposed mechanism was
a decrease in inflammation and/or'a decrease in
26
compartmental pressures .
Summary
DOMS is not an uncommon phenomenon and it has been
experienced by most people. DOMS actually poses a
problem in training and conditioning programs where
individuals have to become physically fit in a short
period of time. In clinical situations soreness may
affect the patient's ability to perform assigned tasks
or to continue rehabilitation (Francis, 1983) . The
actual mechanism of DOMS is not known. It has been
shown with convincing evidence that eccentric
contractions are primarily responsible for DOMS.
Unfortunately, the mechanism by which eccentric
contractions cause the symptoms of soreness and
decreased performance is not truly known. The four
theories that hold merit are: muscle damage, wast,e
accumulation, muscle spasm, and temperalure changes.
When considering atl of the evidence it seems most
logical to choose the first theory, muscl-e damage, ds
the best hypothesis to explain the occurrence of DOMS.
Not only is 1itt1e known about the etiology of
DOMS, but Iittle is known about the treatment of this
problem. The only thing known to decrease pain in
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subsequent exercise is exercise itself. One bout of
exercise has been shown to decrease the amount of
soreness experienced after a second bout of equal
intensity exercise. NSAfDs have been used to treat the
symptoms associated with DOMS. These therapeutic
agents have been shown to decrease pain but. not any of
the other related symptoms experienced. Thus, until
the etiology of DOMS is bet.t.er understood and more
research is completed the general public will have to
continue treating DOMS as the mystery that it truly is.
Chapter 3
METHODS AND PROCEDURES
Within this chapter, the procedures and instruments
that were employed in this st.udy are outlined. The
chapter is divided into five areas: (a) sefection of
subjects, (b) measuring instrument.ation, (c) method of
data collection, (d) treatment of data, and (e) summary.
Selection of Subiect.s
The subjects involved in this study were 1-9 female
college-aged females. Subjects ages ranged from 18 t.o
29 years o1d with a mean age of 22.9 years ol-d. The
subjects were not engaged in act.ive training during
t.his study, however, one subject was a trained distance
runner. Each subject was a volunteer and signed an
informed consent form (Appendix A) agreeing to
participate in the study.
Measurinq Instrumentation
The Kinetic Communicator (Kin-Com) is a robotic,
computerized testing device that. is capable of testing
a person's range of motion, strength, power, and torque
in a specific action. The Kin-Com has been
successfully used as a testing and exercise device
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(Highgenbot.en, 
.Tackson, & Meske, 1988) . The Kin-Com is
functional in three types of contractions: isometric,
concentric, and eccentric. The Kin-Com can also be
used in two different modes, isotonic and isokinetic.
For the purpose of this study, isometric and isokinetic
eccentric contractions were tested, and isokinetic
eccentric contractions were used as the training
exercise. The pain scale used was a lickert-type scale
that requires the subjects t.o quantify the .amount of
discomfort, experienced from 0 t.o 7 (Appendix B) and has
been used'before in a st.udy of DOMS by Sforzo and Lamb
and is known to be reliable and valid (1985) . The
percept.ion of performance scale used was a similar
lickert. scale with ratings from 1 to 7 that requires
t-he subjects to predict how t.hey will perform on the
exercise tests (Appendix C). This scale was designed
specifically for use in this study and the reliability
and validity of this scale is unknown.
Method of Data Collection
Each subject participated in this double blind
study on five consecut.ive days. Before data collection
took p1ace, the subjects were randomly separated into
two groups, a control group (CNT) and a treatment group
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(TRT). The CNT group received the exact same testing,
exercises, and instructions as the TRT however, they
were administered a placebo in place of the treatment
drug, j-buprofen (test procedure summarized in Appendix
D. )
On the first day of data collection each subject
was t.est.ed bilaterally for isometric and isokinet.ic
eccentric strength on the Kin-Com for both the
hamstring and quadriceps muscle groups. Before
t-esting, each subject warmed-up and became familiar
with the Kin-Com and types of exercise that would be
used. The warm-up consisted of 10 submaximal
isokinet.ic contractions, knee extension followed by
knee flexion, dt a speed of 80"/s. The subjects were
given a chance to rest following the warm-up and given
testing instructions. Strengt.h testing consist.ed of
one maximal- isokinetic eccent.ric contraction over the
fuII range of fl-exion and extension at a speed of
30"/s. Isomet.ric measurements were t.aken at a 45"
angle of the knee for 50 s. The Kin-Com provides data
on computer printouts (see example in Appendix E) and
the scores from each t.est were taken from the
printouts, each page of. the printout represents a
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strength test. Eccentric data consisted of the average
torque produced over the entire range of motion and the
isometric value used was peak torque which usually
occurred between 25 and 30 s into the contraction.
After these tests were completed and data stored,
the subject performed 3 sets of 10 maximal repet.ition
eccentrj-c reciprocal exercises at. a speed of L0"/s with
a 5 s relaxation period between each set. These
exercises were performed on only one, randomly selected
leg in an attempt to produce DOMS. Following the
exercise, the subjects were given enough 200 mg
ibuprofen or placebo tablets to last. four days. The
subjects were instructed t.o take one 2OO mg tablet
every four hours beginning immediately following
testing and not to exceed four doses (800 mg) in one
day. Each subject was carefully instructed to take the
medication with milk or a meal to avoid possible
stomach irritation that may be caused by the ibuprofen.
A1so, they were reminded that they did not have to
interrupt their sleep in order to take the drug. The
experimenter monitored t,he administ.ration of the drug
by asking each subject if she took her drug as
requested.
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On the second through fifth day of the study, each
subject, returned for retesting at 24 hour int.ervals.
The subjects completed both the pain and perception of
performance scales for the exercised and unexercised
Ieg and were retested bilaterally for isometric and
eccenLric strength. The subjects did not. repeat the
exercise bout and were reminded to continue taking the
drug as previously described. On the final- test day,
the last dose of the drug was taken at least one hour
before strengt.h measurements were taken.
Treatment of 
.Data
For statistical interpretation of the results,
four separate analyses were employed. First, eight
separate 2 x 5 (group x day) analysis of variance
(AIIOVA) wit.h repeated measures on the second factor
were used t.o examine differences in strength
measurements between the TRT and CNT groups over five
days. The dependent variables were the performance
data for both the exercised and nonexercised 1egs.
Hamstring and quadricep performance scores were peak
torque for the isometric test data and average torque
for the eccentric test data for both the exercised and
nonexercised Iegs. Post-hoc Dunnet tests were used to
33
further define significant findings (Keppe1, L982) .
A 2 x 4 (group x day) repeated measures ANOVA was
used Lo examine the difference in perception of
performance scales as a result of the testing
described. Group reflects either the TRT or CNT and
day was t.he repeated measures scores on the perception
of performance scal-e. A 2 
.x 4 (group x day) repeated
measures ANOVA was also used to examine the difference
in pain scale scores result.ing from the procedures
described. Group reflects either t.he TRT or CNT and
day indicates the repeated measures scores on the pain
sca1e. This statistical test was repeated for each
1ug, exercise type and muscle group. Fol1ow-up Tukey
tests were used as a post.-hoc analysis to locate
significant findings between the test days.
Pearson's product moment correlations were used to
assess the subjects' responses to the pain and
perception of performance scales in relationship to
actual performance for the CNT and TRT groups for the
exercised and unexercised 1eg.
The rejection criterion for the null- hypotheses
was a significance 1eve1 of p < .05 for all- tests. AIt
stat.istical analyses were run using SPSS/PC 4.0 program
34
for the IBM (Norusis, 1990) .
Summary
The subjects in this study were t9 college-aged
femal-es who volunteered to part.icipate in this doubl-e
blind study. After being randomly assigned to the CNT
or TRT group, each subject was t.ested bilaterally for
j-sometric and isokinetic eccentric strength. Each
subject performed three sets of 10 maximal reciprocal
isokinetic eccentric contract.ions of the hamst.rings and
quadriceps with only one I.g, intended to produce DOMS.
The TRT group received 200 mg ibuprofen tablet.s to be
taken four times a day durj-ng the study, while the CNT
group was given a placebo with identical inst.ructions.
On the four days following the initial testing and
exercise, the subjects were asked to complet.e scales
for pain and perception of performance and were
retested for isometric and eccentric st.rength
bi1atera11y.
The performance, perception of performance sca1e,
and pain scal-e data were analyzed using repeated
measure ANOVA, with significant. results tested furt.her
with post-hoc Dunnet and Tukey tests. Correlations
were used to examine the relationship between actual
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performance and the subjects' responses on the pain and
perception of performance scales.
Chapter 4
RESULTS
The resul-ts of the invest.igation into the effects
of ibuprofen on performance in muscles experiencing
DOMS are presented in this chapt.er. The chapter is
divided into the following sections: (a) eccentric
muscle performance, (b) isometric muscle performance,
(c) pain sca1e, (d) perception of performance sca1e,
and (e) summary.
Eccentric Muscle Performance
The four major hypotheses each have subhypotheses
t.hat will be examined in order to make a decision about.
the major hypotheses. To examine the effects of
ibuprofen on eccentric and isometric muscle performance
the subjects were test.ed on bot.h t.heir exercised and
nonexercised legs and the t.wo groups were compared on
hamstring and quadricep performance
Subhlpothesis 1 examines the differences between
the TRT and CNT group in eccentric hamstring
performance over fj-ve days for the exercised 1eg. As
seen in Tab1e L, the repeated measures AIIOVA showed no
significant. difference for the group by day interact.ion
lp (4,58) = 0.60, p > .o5l noi the group main effect
36
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tf' (1, 1-l) = 0.97, P > .051 .
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A significant difference
was indicated upon analysl-s of the day main effect [F
(4, 58) = 4.74, p < .051 (See Figure 1) . Fo11ow-up
Dunnet test (Tab1e 2) showed d significant difference
on day 3 indicating a decrease in muscle strength by
day 3 , 48 hours after the initial exercise bout. The
nul-l- hlpothesis stating that there is no difference
between days was rejected indicating a decrease in
eccentric hamstring performance for al-I subjects on
day 3.
Subhypothesis 2. There is no significant
difference between the TRT and CNT group in eccentric
hamstring performance over five days for the
nonexercised 1eg. Because no significant difference
was found for the group by day effect [f' (4, 58) =
1.34, p > .051 , the group main ef fect, [F (1, ]-7) =
1,.23, p >.051 , nor the day main effect tp (4, 58) =
L.43, p > .051 , the nuII hypothesis was accepted (rabl-e
3).
SubhlEothesis 3. There is no significant
difference between the TRT and CNT group in eccentric
quadriceps performance for the exercised 1eg over five
days. An ANOVA test provided no significant group by
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Table 1
ANOVA Summary for Control and Treat.ment Groups for
Eccentric Hamstrinq Performance for the Exercised Leq
Source SS MS pFdf
Group
Within
Day effect
Group by day
Residual
■3590.47
238922.48
■7277.75
2■68.66
6■ 9■4.99
■3590.47
■454.26
43■9。44
542.■6
9■0.5■
。97   .34
4.74   .002★
。60   .68
■
■7
4
4
68
★pく 05
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Fioure 1. Average eccentric hamstring performance of
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Table 2
Dunnet Test Summarv for Siqnificant. Dav Main Effect.
for Eccentric Hamstrinq Averaqe Torque of the Exercised
Leq
Day■ Day2 Day3Day4 Day5
Means
256.84
228.42
2■7.00
234.95
242.26
Day■
Day2
Day3
Day4
Day5
28.24
39.84★
2■.89
■4.58
■■.42
6.53
■3.84
■7.95
25.267.3■
Critical difference = 35。70′ ★ p く 。05
4■
Table 3
ANOVA Summary for Control- and Treatment. Groups for
Eccentric Hamstrinq Performance for t.he Nonexercised
Leq
Source SS      df      MS       F    p
Group         ■6048。0     ■  ■6048.80   ■.23    .28
withttn       222054.■8    ■7    ■3062.0■
Day effect     3548。44    4      887.■■ ■.43    .23
Group by day   3328.82     4      832.2■ ■.34    .26
Residua1      42■44.25    68      6■ 9.77
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day interaction [F (4, 58) = L.75, p > .05], group main
ef fect. [f' (1, L7) = 0.33, p > .05], nor day main effect
lf' (4, 68) = 2.49, p > .051 (Tab1e 4) and the nuI1
hypothesis was accepted. There was a trend however,
for the treatment group to demonstrate a greater
reduction in strength (Figure 2) .
Subhlpothesis 4. There is no significant
difference between the TRT and CNT group in eccentric
quadriceps performance for the nonexercised 1eg over
five days. No significant difference was found for the
group by day effect tf' (4, 58) = 1.79, p > .051 , the
group main effect, [F (1, a7) = 0.11, p > .05], nor the
day main ef fect tf' (4, 58) = 0.58, p > .O5l (Tabl-e 5) .
The nuI1 hypothesis was accepted.
fsometric Muscl-e Performance
Subhypothesis 5. There is no significant
difference between the TRT and CNT group in isometric
hamstring performance for the exercised 1eg over five
days. No significant group by day effect [r' (4, 58) =
0.35, p > .051, nor group effect, [F (1, ]-7) = 1.58, p
> .051 was found, however, a significant day main
effect tr (4,58) = 2.85, p < .o5l was found (Tab1e 5)
revealing a decrease in performance across the test
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Table 4
AITIOVA Summary for Control and Treatment Groups for
Eccentric Ouadricep Performance for the Exercised Leq
Source SS df MS pF
Group
Within
Day effect
Group by day
Residual-
■57■5。64
799368.98
9653.87
■3827.77
■34■98.82
■57■5.64
4702■.70
49■3.47
3456.94
■973.5■
0.33 57
2.49  .05
■.75   .■5
■
■7
4
4
68
44
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Table 5
ANOVA Summary for Control and Treatment. Groups for
Eccentric Ouadricep Performance for the Nonexercised
Leq
Source SS       df      MSF    p
Group          49■4.07     ■   49■4.07    0。■■ .74
Within       748998。 92    ■7   44058.76
Day effect     489■.07     4    1222.77    0.68   .6■
Group by day  ■2987.66     4    3246。92   ■.79   .■4
Residual     ■23093.48    68    ■8■0。20
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Table 6
ANOVA Summarv for Control and Treatment. Groups for
Isometric Hamstrinq Performance for the Exercised Leq
Source SS       df      MSFp
Group 1-8828.23 1 18828.23 1.58 .23
Within 1,90764.32 L7 L7221,.43
Day effect 17881.96 4 4470.49 2.85 .03*
Group by day 2277 .15 4 569.29 0.36 . 83
Residual 1,0579'7 .39 58 1570.55
* p < .05
between *O-*#**= for isometric hamstring work of
the exercised Ieg was rejected. Post-hoc Dunnet
testing (Table 7) failed to reveal significant findings
across the test days.
Subhypothesis 5. There is no significant
difference between the TRT and CNT group in isometric
hamstring performance of the nonexercised 1eg. No
significant difference was found in the group by day
effect, [F (4,58) = 0.80, p > .05] nor between groups,
tf (1, ]-7) = 30.2, p > .051 , (Table 8) . The day main
effect. was also found to be non significant [.g (4,58)
= 1.55, p > .O5l . The nuII hypothesis was accept.ed.
Subhlpothesis 7. There is no signif icant.
difference between the TRT and CNT group in isometric
quadricep performance of the exercised leg over five
days. There was no significant, difference found for
.05]northegroupmaineffect,[F(1,l7)=1.15,p>
.051 (Tabl-e 9) . Significant val-ues for the day main
effect tf (4, 58) = 4.39, p < .051 , were revealed.
Fol1ow-up Dunnet tests revealed significant differences
between Day 1 and day 5 (Tab1e 10). Figure 3 indicates
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days and the nu11 hypothesis stating no difference
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Table 7
Dunnet Test Summarv for Siqnificatot Day Main Effect
for Isometric Hamstrinq Averaqe Torgue of the Exercised
Leq
;
Day■     Day2     Day3     Day4     Day5
Means
266.79 Day■
233.74 Day2    33.05
228.68 Day3    38。■■    5.06
235。■O Day4    3■.69    .36     6.42
235。95 Day5    30.84    2.2■  7.27     0.85
crtttttcal difference 〓 46.89′  p く .05
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Table 8
ANOVA Summary for Control and Treat.ment Groups for
Isometric Hamstrinq Performance for the Nonexercised
Leq
Source SS       df      MSF   p
Group         32933.70     ■   2933.70    3.02   .■0
Within       ■853■.28    ■7  ■0900.66
Day effect     5428。9■   4    ■357.23    ■.56   。■9
Group by day   2793.24     4     698.3■    0。80  .53
Residua1      59■73.39    68     870。20
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Table 9
ANOVA Summary for Control and Treatment. Groups for
Isometric Ouadricep Performance for the Exercised Leq
Source SS       df      MSF    ⊇
Group         8■ 228.83     ■    8■228.83  ■.■6   .30
Within      ■■92783.59    17    70■ 63.74
Day effect    6■2■4.45     4    ■5303.6■   4。39   .003★
Group by day   5824。34     4     ■456.09   0。42   .80
Residua1     236884.92    68     3483.60
★ p く 。05
5■
Table ■0
Dunnet Test Summarv for Siqnificant Dav Mattn Effect
for fsometric Ouadricep Performance of the Exercised
Leq
Day■     Day2     Day3     Day4    Day5
Means
506.26 Day■
522.74 Day2    ■6.48
509.■O Day3     2.84    ■3.64
534.68 Day4    28.42    ■■.94  25.58
576.47 Day5    70.2■★ 53 73    67.37    4■.79
Critical difference = 69.84, *p < .05
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Fttqure 3.  Pea卜 iSOmetric quadricep perfOェlllance of the
exercised leg for five days. ★ Denotes significant
difference between day l and day 5。
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that the subjects increased their performance by day 5
when compared to the initial test day. The null
hlpothesis that stated there was no difference between
the TRT AND CNT groups in isometric quadricep
performance of the exercised leg was rejected.
Subhvpothesis B. There is no significant.
difference ietween the TRT and cNT group in isometric
quadricep performance of the nonexercised 1eg over five
days for the group main effect, [F (1, 77) = 1.11, p
>.051, group by day ef fect [F (4, 68) = 1,.52, p >
.051 (Tab1e 11), nor the day main effect tF (4, 68) =
L.22, p > .051 and the nulI hypothesis was accepted.
Pain Sca1e
Repeated measure ANOVA (2 x 4) was performed to
test the validity of the nul_I hlpotheses on pain scale
scores and muscle performance.
Subhvpot.hesis 9. There is no signif icant
difference between the amount of pain reported on the
pain scale between the TRT and CNT groups for the
exercised 1eg. As seen in Table L2, there was no
significant difference for t.he group main effect, IF
t, L'7) = 2.67, p > .051 nor the group by day
interaction, [F (3, 51) = ]-.31, p > .051. A
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Tabl-e 11
ANOVA Summary for Control and Treatment Groups for
Isometric Ouadricep Performance for the Nonexercised
Leq
Source SS       df      MsF   p
Group         85862.52     ■   8 862.52    ■.■■ .3■
Within      ■3■6230.32    ■7 77425.3■
Day effect    22405。 42     4    560■.36 ■.22 .3■
Group by day  28■■4.73     4    7028.68    ■.52   .20
Residua1     3■ 3452.37    68    4609。59
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Table 1"2
ANOVA Summary for the Cont.rol and Treatment Group for
Pain Scale Responses for the Exercised Leq
Source SS     df     MS      F    p
Group
Withttn
6.24      ■    6.24     2.6■   .■2
40.68     ■7       2.39    '
Day effect     28.96      3       9.65    ■5.09 .00★
Group by day    2.52      3       0.84     ■.3■ .28
Residua1       32.63     5■       0.64
_★p く .05
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significant day main effect [f' (3, 51) = 15.09, p <
.051 finding was followed by a post-hoc Tukey test
which revealed significant differences on day 2 and day
3 (Table 13), indicating a recovery from the soreness
by day 5 across all subjects, and the null hypothesis
stating.no difference for pain scale responses for the
exercised Ieg was rejected
Subhlpothesis 10. There j-s no signif fcant
difference between the amount of pain reported on t.he
pain scale between the TRT and CNT group for the
nonexercised Ieg. The repeat.ed ANOVA showed no
significant difference for the group main effect, IF
(1, L7) = 0.26, p > .O5l nor for the group by day
.interaction, [p (3, 51) = 0.53, p > .05] . A
significant finding was reported for the day main
effect, [F (3, 51) = 4.51, p < .05] (Table 14).
Fol-l-ow-up Tukey test revealed no significant.
differences.across four test days (Tab1e 15), thus the
Tukey test was unable to further define the differences
across the days. The nul-I hypot.hesis stating that
there is no difference between the two groups for pain
scales responses for the nonexercised 1eg was rejected.
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Table ■3
Tukev HSD Post Hoc Analystts of the Siqnttficant Dav Main
Effect for Pain Scale RespOnse for the Exercised Leq
Day2      Day3      Day4      Day5
Means
■.97  Day2
2.34  Day3     0.37
■.54  Day4     0.43      0.80
0.68  Day5     ■。29★     ■.66★     0.86
Critical difference = 1.01, * p < .05
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Table L4
ANovA summary for contror and Treatment Groups for pain
Scal-e Response for the Nonexercised Leq
Source
′
SS      df      MS      E     p
Group           o.20      ■       o.20     0.26   .62
Wttthin         ■3.■5 ■7       0。77
Day effect      4.27      3       ■.42     4.5■ .007★
Group by day    O.59      3       0.20     0.63   .60
Resttdua1       16.■0  5■      0。32
★ p く .05
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Tab■e ■5
Tukev HSD Post Hoc Analysis ttOr the sttqnificant Dav
Mattn Effect for Pain Scale RespOnses for the
Nonexerc■sed Leq
Day2      Day3      Day4      Day5
Means
O.69  Day2
0.92  Day3     0。23
0。80  Day4     0.■■     0。■2
0。28  Day5     0.4■   0。64      0.52
Critical difference = 0.77, * p < .05
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Perception of performance Scale
The nu11 hypothesis on perception of performance
was tested using a repeated measure ANOVA. Several
subhypotheses were tested to help examine the major
nul1 hypothesis.
Subhypothesis 11. There is no significant
difference between TRT and CNT group in the percept.ion
of the subjects ability to perform eccentric work with
the exercised 1eg. As seen in Table a6, t.he repeated
measures ANOVA showed no significant difference between
t.he t.wo groups for the group by day interaction [f' (3,
51) = 0.25, p > .O5l nor the group main effect tp (1,
L7) = 2.54, p > .051 , however a significant. resul_t for
the day main effect. was detected [f' (3, 51) = 9.44, p <
.051 and the nuI1 hlpothesis was rejected. FoIIow-up
Tukey test demonstrated a significant difference
between day 2 and day 5, and day 3 and day 5 (Table 1-7)
indicating that the subjects were increasing
performance perception by the last day.
Subhypothesis 12. There is no significant
difference between TRT and CNT group in the perception
of t.he subjects' ability to peiform eccentric work with
the nonexercised leg. The repeated measures ANOVA
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Table L6
ANOVA Summary for Cont.rol and Treatment Groups for
Perception of Performance scale Response for Eccentric
Work of the Exercised Leq
Source SS     df     MS     旦 ⊇
Group           3.28      ■       3.28     2.54   .■3
Wttthttn         2■.96   ■7      ■.29       '
Day effect     24。46    3       8.■5  9。44   .00★
Group by day    O.67      3       0.22     0.26   .85
Residua1       44.07     5■      0。 86
★p く 。05
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Table ■7
Tukev HSD Post Hoc Analysitt Ωf the siqn tficant Dav Main
Effect for perception of ⊇erfQrmaュ⊆e scale RespOnses
for Eccentrttc Work of the Exercttsed Leq
Day2      Day3      Day4      Day5
Means
3.■O  Day2
3.00  Day3     0。■0
3.68  Day4     0.58      0.68
4.42  Day5     ■.32★     ■.42★     0.74
Critical- difference = 7.L7, * p < .05
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showed no significant difference between the two groups
for the group by day j-nteraction [f' (3, 51.) = 1.8G, p
> .051 (table l-8) and the null- hypothesis stating that
there was no difference between groups for perception
of ability to reform eccentric work of the nonexercised
1eg was accepted
Subhypothesis 13. There is no significant
difference between the TRT and CNT group in the
perception of performance in isometric performance for
the exercised 1eg over four days. There was no
interaction, [r' (3, 51) = 0.25, p > .05] , nor the group
main effect, [F (1, A7) = 2.74,. p , .05]. A
significant difference was found for the day main
effect, [F (3, 51) = 8.70, P < .05] (Table 19) and t.he
nul1 hypotheses was rejected. Post-hoc Tukey HSD test
(Tab1e 20) reveal-ed significant differences between the
days 2 and 3 compared to day 5, indicating that. the
subjects improved their perception of performance by
day 5 compared t.o 24 and 48 hours after the inducement
of soreness.
Subhypothesis 14. There is no significant
difference between the TRT and CNT groups in the
perception of performance in the isometric performance
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Tabl-e 18
ANOVA Summary for Control- and Treatment Groups for
Perception of Performance scare Responses for Eccentric
Hamstrinq Work of the Nonexercised Leq
Source SS df MS F p
Group L.66 I 1,.56 I .52 .23
Within 18.53 1-7 1. 09
Day effect 2.66 3 0. 89 1. BG .15
Group by day 1.03 3 0.34 0.72 .54
Residual- 24 .29 51 0.48
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Tab1e L9
ANOVA Summary for Control- and Treatment Groups for
Perception of Performance Scale Responses for Isometric
Work of the Exercised Leq
Source SS      df      Ms      E    p
Group     `      5。9■       ■      5。9■     2.74   .■2
Within         36.6■       ■7      2.■5
Day effect     ■9.94      3      6.65     8。70   .00★
Group by day    O.57       3      0。■9     0.25   。86
Residua■       38.95      5■    0。 76
★p く 。05
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Table 20
Tukev Post. Hoc Analysis of Siqnificant. Day Main Effect
for Percept,ion of Performance Scale Responses for
Isometric Work of the Exercised Leq
Day2      Day3      Day4      Day5
Means
3.32  Day2
3.■2  Day3     0。20
3.74  Day4     0.42      0.62
4.47  Day5     ■.■5■     ■.35★     0。 73
Critical difference ≡ ■.■0′ ★ p く 。05
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for the nonexercised 1eg over four days. There was no
significant difference found for the group by day
effect, [F (3, 51) = 0.38, p > .05], the group main
effect, [F (1, l]) = 1-.57, p > .051 , nor for the day
main effect, [F (3, 51) = 2.21", p > .05] (Tab1e 2a) ,
and the nuII hypothesis stating t.hat there was no
difference between groups in perception of performance
for the isometric nonexercised 1eg over four days was
accepted.
In order to test the effectiveness of the
percept.ion of performance scal-e as it relat.es to actual
performance, Pearson Product Moment correl_ations were
computed and are reported in Table 22. In general, the
perception of performance was not related to actual
performance for either the exercised or nonexercised
Ieg.
To test the effectiveness of the pain scale as it
relates to actual performance Pearson Product Moment
correlations were also computed and can be seen in
Table 23. Three significant negative relationships
were found between t.he subjects perception of pain and
actual performance for the CNT group in isometric
hamstring and quadricep and eccentric hamstring work of
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Table 2l
ANOVA Summary for Control and Treat.ment. Groups for
Percegtion of Performance Scale Responses for fsometric
Work of the Nonexercised Leq
Source SS     df     Ms      二 2
Group
Within
■.9■       ■      ■.9■     ■.57   .23
20。73      ■7     ■.22
Day effect      2.4■       3      0.80     2.2■ .■0
Group by day    O.4■       3      0.■4     0.38   .77
Residual       ■8。49     5■    0.36
★p く .05
Tabl-e 22
Pearson Product Moment Correlations for the Perception
of Performance Scale Responses and Actual Performance
for t.he Exercised and Nonexercised Leq
EXERCISED LEGNONEXERCISED LEG
CNT
(N=9)
TRT
(N=8)
CNT
(N=9)
TRT
(N=8)
fsometric
Hamstring
Quadricep
Eccentric
Hamstring
Quadricep
―.■4
-.■■
.06
.■2
―.02
-.02
.■3
.08
―。24
-.32★
―。■8
-.■7
。27
.2■
???
?
???
?
★ p く 。05
―・
―
|
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Table 23
Pearson Product Moment Correlations for the Pain Scal-e
Responses and Actual- Performance for the Exercised and
Nonexercised Leq
EXERCISED LEG NONEXERCTSED LEG
CNT     TRT       CNT        TRT
(N=9)   (N=8)     (N=9)      (N〓8)
Isometric
Hamstring - .48* .01- -.39* -.10Quadricep - .33* .04 -.30* .37*
Eccentric
Hamstring -.51* -.14 -.50* -.18Quadricep -.19 .10 - .43* .22
★ p く 。05
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the exercised Ieg. The CNT group also demonstrated
significant findings for al-I measures of work for the
nonexercised 1eg. Although seven of the eight
correlations between pain scale reports and actual
performance were significant. for the CNT group, t.here
was only one such finding for the eight correlations
run for the TRT group.
Summary
ANOVA resul-ts indicat.ed that t.here was a decrease
in the subjects' performance over the test days.
Signif icant results for t.he day main ef fect were .found
for the exercised or sore 1eg in isometric hamstring
and quadricep work, and eccent.ric hamstring work.
There was no interact.ion between the TRT and CNT groups
upon analysis of the performance of the exercised 1eg.
There were no significant results for either the
isometric or eccentric work for the nonexercised 1"g,
regardless of muscle group.
Significant interactions between the TRT and CNT
groups were not established for pain scal-e reports on
the exercised or nonexercised 1eg. A day main effect
was revealed for both the exercised and nonexercised
leg. FoI1ow-up Tukey HSD tests revealed that
?
?
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significant mean differences for the exercised Ieg,
indicating that. the subjects recovered from soreness by
day 5 when compared to days, 2 and 3.
Analysis of the perception of performance results
with an ANOVA revealed signi ficant day main effects for
both isometric and eccentric'p".for*ance of the
exercised 1eg. Tukey HSD. post-hoc tests located the
significant mean differences between days 2 and 3 when
compared to day 5, demonstrating a recovery from the
amount of soreness experienced by the 1ast. day of
testing. Significant effects were not established for
the nonexercised Ieg.
The perception of performance correlation result.s
indicated that the subjects' responses to the
percept.ion of performance scale were not in l-ine with
actual- performance for the TRT and CNT group regardless
of test. condition. The pain scale correlations
revealed that there was a significant. negative
relationship between the responses and act.ual-
performance for a1l- CNT measures except one, but. this
was not the case for the TRT group where only one of
eight correlations was significant.
Chapter 5
DISCUSSION OF RESULTS
The significance of this study's findings will be
discussed in this chapter. The effects of DOMS and
ibuprofen will be reviewed in the following sections:
(a) 'ibuprofen and muscle performance, (b) ibuprofen
and pain, (c) ibuprofen and perception of performance,
and (d) summary.
fbuprofen and Muscl-e Performance
Studies have investigat.ed the effects of NSAfDs
and muscle performance when a muscle is experiencing
DOMS and ibuprofen is known to have analgesic and anti-
inflammatory effects (Francis & Hoobler, 1987). The
present. study found no significant effect for 'eccentric
or isometric performance when comparing the ibuprofen
and placebo groups. A previous study also found no
effect of ibuprofen on sore muscles performance whil-e
producing peak torque eccentrically or concentrically
(Grossman et dI., 1995). A third study also found no
difference between ibuprofen and placebo for isometric
quadricep strength (Donne1ly et dI. , 1990) . Similarly,
the present study found that the administ,rat.ion of
ibuprofen after induction of DOMS failed to prevent
73
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decrements in muscle 
.performance.
Hasson et aI. (1993) found t.hat eccentric peak
torque was significantly lower for a group who received
prophylactic ibuprofen when compared to therapeutj-c
ibuprofen, this study differs with the present study as
' well as Grossman's (l-995) . A possible explanation is
that Hasson used both men and women and did not. account
for the absolute strength difference between males and
females.
Hasson et aI. (1988) found that high speed
voluntary contract.ions reduced the effects of DOMS and
restored normal muscle performance. Another study
indicated that repeated intense eccentric exercise
progressively decreased soreness after t.he first
several days (Friden, Seger, Sjostrom, & Ekbolm, 1983).
Therefore, although using treatment. appears
ineffective, subsequerit. exercise may be a means to
mitigate the negative impact of DOMS on performance.
It is commonly accepted that DOMS pain peaks 24-72
hours after an unaccustomed task (Armstrong, 1984). A
relationship between increasing pain and decreasing
performance would predict that performance deficits
woul-d al-so be maximized at about 48 hours after the
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unfamiliar task. In the present study, the performance
decrease peaked 48 hours after the initial exercise as
did subjective assessment of pain. Because muscle
performance decreased secondary t.o the onset. of DOMS,
one can conclude that ibuprofen did not sufficiently
d.ecrease the injury mechanism to'aI1ow for greater
performance of the treatment group than the control
gioup. Addit.ionally, the subjects' performance
recovery by day 5, suggest.s t.hat all gradually
recuperated regardless of treatment.
Ibuprofen and Pain
Treatment of DOMS has been studied by a variety of
means with limited success for pain relief. Aspirin,
ibuprofen, and diclofenac (an NSArD) have been studied
as pharmaceutical management techniques. Aspirin has
been shown to attenuate muscle soreness but had no
effect on isometric muscle strength recovery (Morin &
clarkson, 1990) . one study found that diclofenac did
not reduce overall muscle soreness for subjects
suffering from DoMs (Donnelly et dI., 1988). Muckle
(L974) examined the effects of ibuprofen compared to
aspirin in soft-tissue injuries and found ibuprofen
reduced pain significantly more for the first three
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days after injury. Hasson et aI. (1993) found that the
prophylactic administration of ibuprofen will attenuate
.the symptoms of DOMS, however, the therapeutic use of
ibuprofen provided no reduction in symptoms. A similar
study by Grossman et a1. (1995) found that prophylactic
and therapeutic treatment with ibuprofen had no effect
on pain when compared to t.he placebo.
The current study, using only therapeutic
ibuprofen, al-so demonstrat.ed that subjecLs experience
equivalent soreness secondary to eccentric exercJ-ses,
with or without ibuprofen. Thus, 800 mg of ibuprofen
is insufficient in decreasing the pain effects of DOMS,
however, within three days pain begins t.o subside
regardless of treatment.
The present study found a significant j-ncrease in
pain for the nonexercised leg in both the TRT and CNT
groups. A possible explanat.ion for the significant
finding might be that the baseline eccentric testing,
an unaccustomed task, caused enough muscle damage to
elicit a pain response. Another possible explanation
is that these muscle became sore from providing
stabilizing forces during the soreness induction
protocol for the contralateral timb.
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Ibuprofen and Perception of performance
The relationship between the therapeut.ic
administration of ibuprofen and perception of
performance has not been previously investigated. The
present study indicat.es that subjects had similar
perceptions of their ability to perform regardless of
test condition. Additionally, no relationship was
found between their perception of performance scores
and actual performance. However, there was a
significant negative correlation between the CNT
,group's pain scale responses and their actual
performance. The TRT group did not have a similar
relationship between pain scal-e scores and performance.
Perhaps ibuprofen did affect the relationship between
perception of pain and performance and the perception
of performance scal-e was not a well conceived
assessment tool. This argument is difficult to justify
because there was no difference between groups on pain
scale results. A study, specifieally examining the
effects of ibuprofen on perception of performance,
would be valuable because of the potential harmful
sit.uation that could exist if ibuprofen masked
perceptions of abilit.y in athl-etics.
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Summary
This study investigated the effects of ibuprofen
on DOMS, specifically whether ibuprofen would affect
performance, pain, or perception of performance while
suffering with DOMS. The results of this study are
consistent with several other studies. Although
ibuprofen has been shown to be somewhat effective when
administ.ered prophylactically, it can be concluded from
the current study that 800 mg of daily t.herapeutic
ibuprofen does not decrease the negative effect.s of
DOMS on isomet.ric or eccentric -muscle performance, nor
pain. The investigation into the effects of ibuprofen
on the subject percept.ion of performance also reveal-ed
no effect of ibuprofen, when one only considers the
perception of performance scale responses in
relationship to performance. Closer examination of the
pain scale responses in comparison to actual-
performance indicates that the CNT group had a moderate
hegative correlation between pain scores and
performance. Accordingly, there seems to be a
relationship between the amount of soreness experienced
and the ability to perform isometrically or
eccentrically, however this relationship becomes less
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apparent after the administration of ibuprofen. In
this study, the pain scafe was a prediction tool than
the perception of performance scale for actual
performance.
Chapter 6
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
This'chapt,er presents an overview of the entire
experiment and is divided into three sections: (a)
summary, (b) conclusions, and (c) recommendations for
furt.her study.
Summarv
The purpose of t.his study was t.o investigate the
effects of ibuprofen on persons expe.riencing DOMS.
Whether ibuprofen would influence the amount of pain,
subjects' perception of performance or actual
performance of the hamstring and quadricep muscle
groups in eccentric and isometric contractions was
investigated.
To obtain results, L9 college-aged women
volunteered to participate and signed an informed
consent form. Each subject participated in this double
blind study for five conseCutive days. Prior to data
collection, each subject was randomly assigned into
either the TRT or cNT group, with both groups receiving'
identical- instructions, exercJ-ses, and testing. The
CNT group received a placebo in place of the treatment
drug, ibuprofen. On the first day of testing, each
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8l_
subject was tested bi1at.era11y for isometric and
isokinetic eccentric strength of the hamstring and
quadricep muscle groups on the Kin-Com dynamometer.
After t.he strength tests were completed, each subject
performed 3 sets of l-0 maximal eccentric reciprocal
exercises with one 1.9, in an attempt to produce DOMS.
The eccentric contract.ions were performed at a speed of
1-O"/s with a 5 s relaxation period between sets.
Foll-owing these soreness inducing exercises, each
subject was given enough 200 mg ibuprofen or placebo
tablets to last four days with instructions for
administration
On the second through fifth day, each subject
returned for retesting at 24 hour intervals. Upon-
completion of pain and perception of performance scales
for the exercised and unexercised 1"9, the subjects
were retested for all strength measurements. The
subjects were reminded to take the medications and on
the final day of testing the last dose of the drug was
taken at least one hour before strength measurements
were t,aken.
Data was examined with a 2 x 5 (group x day) ANOVA
with repeated measures on the second factor to examine
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differences in strength measurements. Significant
results were followed by post-hoc Dunnet. tests to
clarify their meaning. These tests revealed a
significant. difference in performance of the exercised
hamstring on day 3 compared t.o baseline data (day 1) .
DOMS proved to be a factor in decreasing subsequent
performance of the involved muscles in both eccentric
and isometric contractions. A 2 x 4 (group x day)
repeated measures ANOVA examined t.he difference in
perception of performance and pain scal-e responses as a
result of the testing described. Using Tukey posL-hoc
tests, the pain scale results revealed that the
eccentric exercises did indeed produce DOMS, peaking 48
hours after exercise. Pearson's product moment
correlations showed that the perception of performance
scale was not correl-ated with the subjects actual
performance, however, the pain scale had a moderate
negative correlation with actual performance for t.he
CNT group. Thus indicating that perhaps the pain scale
response was a better indicator of the subsequent
performance than the perception of performance scale
and that ibuprofen may have impacted the relationship
between pain sensations and performance.
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Conclusions
1. The daily therapeutic administration of 800 mg
of ibuprofen after the induction of DOMS does not
improve eccentric or isometric performance for the
hamstring or quadricep muscle groups.
2. The daily therapeutic administ.ration of 800 mg
of ibuprofen has no effect on the amount of pain
perceived after performing eccent.ric exercises to
induce DOMS.
3. The daily therapeutic administ.ration of 800 mg
of ibuprofen has no effect. on percept.ion of performance
after soreness had been ihduced performing eccentric
contractions.
4. Ibuprofen may affect the rel-ationship between
pain perception and actual performance for the
exercised and nonexercised 1eg under eccent.ric or
isometric conditions. Pain scale responses, for the
CNT group onIy, indicated that when they were reporting
more pain their performance decreased.
Recommendations for Further Studv
The following recommendations are being made for
further research on this subject:
1. The subjects only performed one set of 10
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eccentric exercise to induce soreness. A greater
number of sets/repetitions might cause the subjects
greater amounts of soreness and result in more
significant. decreases in performance and perception of
performance. Such manipulation might be more sensitive
to treatment.
2. Smaller muscle groups might be used in order
to produce a significant amount of soreness more
easily. Additionally, smaller muscle group use might
al-Iow for more objective measures of injury including
range of motion and girth measurements, ds well as
limitation of daily muscle use. Larger muscle groups
are more difficult to immobilize or limit use of on a
daily basis.
3. The pain and perception of performance scales
could be enhanced ff the two were more simil-ar Lickert-
type scal-es so that the subjects' responses might be
related more.efficiently. A1so, the subjects' should
respond to the scales for each muscle group and test
condition, allowing for more specific j-nformation
rather than generalizing for dynamic and static
efforts. A study should be carefully designed to
investigate if ibuprofen limits perception of
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performance capabilit,y for athletes in any manner.
, 4. A propihylactic and/or t.herapeutic exercise
'I
treatment group could be used to could explore the
theory that exercise is the best treat.ment for DOMS.
Appendix A
Informed eonsent Form
Purpose of the Study
This study, approved by the Ithaca College Human
Subjects Committee, has been designed to investigate
the possibility that ibuprofen will improve performance
and decrease pain in a muscle group suffering from
muscle soreness.
Benefits of the study
The results from this study will help sports
medicine related professionals to better understand the
effects of ibuprofen when it. is administered to
athletes with muscle soreness. This will provide
insight to how muscle soreness may be treated for
athletic injuries or muscle soreness due to
unaccustomed work (e.g. painting). Another benefit
from this study will be the possibility t.hat.
performance may be affected by the treatment and
athl-etes as well as regular exercisers would be
interested in that information.
Subject's initials.
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Subi ect partici-pation
You will be asked to perform several bouts of
exercise and complete some pain and perception scal-es.
The exercise will be maximal resistive exercises of the
upper 1eg muscles. A11 exercises will be performed on
the Kin-Com, a computerized isokinetic instrument used
to interpret the amount of work performed during a
specific movemenL. These bouts of exercj-se are
designed t.o test power and strength. After the first
day of exercise it is expected that you will experience
some muscle soreness and discomfort. After exercise
the subject will be asked t.o t.ake a 200m9 dose of
ibuprofen (e.g., Motrin) every 4 hours until the next
day. 200m9 is a st.andard over the counter, non-
prescription dose. You will- be asked to perf orm t.he
same exercises for five consecutive days and t.o
continue to take the ibuprofen up until one hour before
your exercise bout on the last day of the experiment.
AIso on the second day and each subsequent day you will
be asked to complete two questionnaires. The first.
question is a pain scale and the second is a perception
Subject's initials
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of performance sca1e. These scales will aid in the
interpretation of the data received from the exercises.
Tota1 participation time for each subject is expected
to be 45 minutes on the first day of the study and
about 15 minutes for each of the following days. The
experiment wil-I be conduct.ed in Smiddy Ha1I Physical
Therapy Laborat,ories and should not involve your
working up a big sweat; therefore, you may wear street.
clothes to each t.est. session and should not have to
take a shower following the brief exercise. Actual
exercj-se will last less than one minute on most days.
Risks that may be invol-ved with participation
This study will cause you t.o experience muscle
soreness. Everyone has experienced this type of
discomfort at one point or another in their lives. The
muscle soreness that you'will experience will be of a
transienL nature and has a duration of only a few days.
The pain will subside as normal function returns to the
muscles. The amount of soreness you experience should
not interfere with your normal daily activities.
Maximal resistive exercise cannot be performed
Subject's initials
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wit.hout some minor risk of injury. To minimize the
risk of injury all precautions will be taken. The Kin-
Com is a very safe and effective exercise device and
the researchers are well trained on the machine.
Exercise will be supervised at all times by at least
one of the researchers.
fbuprofen is an over the counter drug that has
been approved by the FDA and is considered safe for
general consumption. Ibuprofen should not. be taken if
you have an intolerance to aspirin or non-aspirin pain
rel-ievers such as TyIenoI. Some of the possible side
effects of this drug are upset stomach, blurred vision,
rash, weight gain, and retention of fluids. These side
effects are not common among the majority of people and
are extremely unlikely with the short term use involved
in t.his study. Ibuprofen should be taken with meals or
a glass of milk.
In summary, this project involves only safe
experimental protocols that are commonly used in
exercise physiology research. rt is not expected to
result in any long term inconveniences or pain for you
Subject's initials
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and will hopefully provide information of great
interest to sports medicine expert.s, coaches, athletes,
and all those that exercise.
Need more information?
ff you would like more information about this
study or would like to know the results of the study,
please feel free to contact Theresa Glackin at 256-
4032. Dr. Gary Sforzo, professor in the Exercise and
Sport Science Department, will al-so be able to answer
your questions. He may be contacted in his office room
4a, Hill Center, ext. 3359.
Withdraw from the study
Participation in this st.udy is voluntary, and you
are free to withdraw at any time. If you have
quest.ions about the study or its procedures we will- be
happy Lo answer them before or after you agree to
become part of t.he study. If you choose not to
participate in this study you will not suffer any
academic or athletic consequences.
Subj ect' s init.ials.
9L
Will the data be maintained in confidence?
A11 of the participants in the study wil-l- be given
a number code that will be used whenever related data
is analyzed or presented. A11, data, answers t.o
questionnaires, and results will be kept. complet.ely
confidential.
Thank you for your time in considering this study
and more i-mportantly for participating.
I have read the above and I understand its contents. I
am over the age of 18 years ol-d and fuIly agree to
participat.e in the study.
Signature Date
Appendix B
IdentificatiOn Number
Date
SORENESS RATINC SCALE
Exerclsed
Unexercised
??
? ?? （ ? ）
?
Vague pain light pain than
slight pain
〇“060
①60
paln Vague pain ght pain thanPainful
slight. pain
llc pain 
- t.tild, bare).y perceptible slrnpLcms of pain
Vagn-e pain 
- DuII ache upon palpation
sIigh.E pain 
- PersisEent disc.onfort, but does not interfere wit.h n()v*n'c.rl
lbre tlun slight. pain 
- Soreness which hamprers ccrnll.tex rrr)vcrnnt
Paijtfur 
- consLant pain and stiffness which interfcres wj.Lh rTx)st (laiJy lir::I,.:i
very painful 
- Continual pain without rpvernent,
F:<trerely painful 
- Severe soreness, intoler:aLlle Llrr.Lrlrirrq lvrirr
Iixt retrcl y
lrrirrful
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Pa inful
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Appendix C
Perception of Performance Scale
Subject Number
Date
Complete the following statements with the answer thatbest suits the way you feel today. Please take you time
and read the statements carefully.
Exercised Leq
Today, in comparison to my previous test (s) , I feelthat my isometric strength performance will be
■       2          3         4        5         6        7
much somewhat slightly the same slightly somewhat much
weaker weaker weaker better better better
Today, in comparison to my previous test (s) , I feelthat my dynamic strength performance will be
■     2       3       4.      5       6      7
much somewhat slightly the same slightly somewhat much
weaker weaker weaker better better better
93
94
Subject. Number
Unexercised Leq
Today, in comparison to my
that my isometric strength
previous test (s) , I feelperformance will be
much somewhat
weaker weaker
slightly the
weaker
same slightlybetter somewhat muchbetter bett.er
Today, in comparison to my previous test. (s) , I feel
t.hat my dynamic strength performance will be
1,2 4
much somewhat
weaker weaker
slightly the
weaker
same slightly somewhat muchbet,ter better better
■       2          3         4        5          6        7
Appendix D
TEST PROTOCOL
The foll-owing is an outline of the test protocol used
for each day of this study:
DAY 1
1. The subject arrives and competes the informed
consent form.
2. The subject is familiarized with the Kin-Com and
given the opportunity to try the exercises that
will be used in the study.
3. Isometric hamstring strength is test.ed at 70" of
knee flexion, with three isometric trials and the
average of the peak torque is used as the
subject's score.
4. Isometric quadricep strength is tested in the same
manner.
5. Eccentric strength is test,ed using reciprocal
patt.erns with t.he hamstrings working before the
quadriceps. The test range is from 80" to 10" of
knee flexion. The subject performs three t.ests
and the average force is the subject's score.
5. Exercises is performed next. The subject
exercises only one 1eg with three sets of 10
95
96
repetitions of reciprocal hamstring and quadricep
eccentric contractions. The subject is given a 30
second rest period. The subject is instructed that
each muscle contraction should be of maximal effort.
7. After completion of the exercise bout, the subject
is giv'en an envelope with enough of either the
placebo or treatment drug for the next five days.
The subject is instructed to take one piI1 every
four hours until the last day of the study. The
subject is cautioned to take the piII with milk or
a meal to void stomach irJitrtion as well- as not
to interrupt her sleeping in order to take the
medication.
Day 2-5
1. The subject completes the pain and perception of
performance scales.
2. The subject is retested for isometric and
eccentrj-c muscle strength on both legs for the
hamstring and quadricep muscle groups. (See test
procedure stated above) .
3 . The subj ect is reminded about t,he proper
administration of the t.est drug.
Appendix E
Kin-Com Test Results
The following is a copy of the printout produced by the
Kin-Com. The printout indicates the subject's average
torque for eccentric performance and peak torque for
isometric performance .
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Appendix F
Standard DeviationsMeans and
Isomenteric Hamstring
Entire popu■ation
Group  control
Day ■
Day 2
Day 3
Day 4
Day 5
Group Treatment
Day ■
Day 2
Day 3
Day 4
Day 5
1somenteric QuadriCep
Entire Popu■attton
Group  control
Day ■
Day 2
Day 3
Day 4
Day 5
Group  Treatment
Day ■
Day 2
Day 3
Day 4
Day 5
Perfoェlllance of
Mean
240.05
2■7.24
237.80
2■3.80
200。80
2■5。90
2■7.90
265.40
299.00
255。89
259。67
256.44
256.00
Perfoェlllanc  of
Mean
529.85
5■3。,92
480。80
500。70
503.00
525。80
559。30
547.55
534.55
547.22
5■5.89
544.55
595.55
・■07
Exerc■sed
Std Dev
62.94
63.67
47。77
53.26
75。23
75.23
72.■0
5■.96
68.72
46.■9
5■.98
46.59
39.0■
Exerc■sed
Std Dev
■27.32
■29。40
■■8。26
■37.36
■33.■2
■44。22
■25。72
■23.99
■34。25
■34.42
■26。98
■30。2■
■07.06
Leg
Leg
―
|
■08
Eccentric Hamst.ring
Entire Popu■ation
Group  contro■
Day ■
Day 2
Day 3
Day 4
Day 5
Group Treatment
Day ■
Day 2
Day 3
Day 4
Day 5
Eccentric Quadriep
perfoェlllance of
Mean
235。89
225。72
246。■0
2■8.30
2■4.80
2■8。70
230。70
247.20
268。78
239。67
2■9.44
253.00
255。■■
Exerc■sed Leg
Std Dev
59。33
65。56
64.66
64。93
7■.08
75。■■
59。75
49.86
63.68
52.92
46.80
44.87
32.43
Exerc■sed Leg
Std Dev
■0■.40
■■2.78
■■3.62
■■4。■8
■■3.02
■27.■7
■■6。66
88.26
88.04
75.5■
■■3。92
■0■.67
53.50
Performance of
Entire Population
Group  Control
Day ■
Day 2
Day 3
Day 4
Day 5
Group  Treatment
Day ■
Day 2
Day 3
Day 4
Day 5
Mean
4■7.59
4■5。40
422.90
405。80
402.40
4■■.90
434.00
420.02
454.00
42■.22
386.■■
436.00
402.78
■09
Isometric Hamstring
Entire Popu■ation
Group  control
Day ■
Day 2
Day 3
Day 4
Day 5
Group Treatment
Day ■
Day 2
Day 3
Day 4
Day 5
1sometric Quadrttep
Perfoェlllance
Mean
240.27
227.08
226.80
2■7.50
2■2.90
232.90
245。30
254.93
243.22
257.89
254.00
257.00
262.56
of Nonexercised Leg
Std Dev
Performance of
53.73
57.8■
43.29
55.35
75。7■
53。72
62.53
45.02
44.46
43.■
43.74
53.58
47.87
Exerc■sed Leg
Std Dev
■34.04
■43.57
■67.34
■63.55
■35.■8
■39。34
■23.58
■23.56
■00.60
■29。26
■38.50
■56.30
■09。95
Entire POpulation
Group  ControI
Day ■
Day 2
Day 3
Day 4
Day 5
Group  Treatment
Day ■
Day 2
Day 3
Day 4
Day 5
Mean
520。42
5■2.■6
478.30
5■2.90
482.20
547.20
540。20
529.60
529.56
528。44
537.89
550.33
50■.78
■■0
Eccentric Hamstring
Entire populattton
Group  contro■
Day ■
Day 2
Day 3
Day 4
Day 5
Group Treatment
Day ■
Day 2
Day 3
Day 4
Day 5
Eccentric Quadriep
Perfoェlllance
Mean
243。■0
236.78
236。90
232.80
223.50
237.20
253.50
250。■3
253.33
256。22
25■.33
236.22
253.56
of Nonexercised
Std Dev
54.■3
59。94
60.5■
6■.24
67.75
50。72
66.82
46.50
5■.■■
45。63
57.92
33.98
48。99
Leg
Entttre Population
Group  contro■
Day ■
Day 2
Day 3
Day 4
Day 5
Group  Treatment
Day ■
Day 2
Day 3
Day 4
Day 5
Performance of Nonexerc■sed Leg
Std Dev
97.63
■02.63
■■0。7■
■08.59
■■■.45
93.90
■06.58
92.■4
■■■.4■
90。■5
93.■6
94.99
83.93
Mean
426.68
4■8。92
4■4。40
420。60
402.80
4■9。20
437.60
435。3■
458。44
446.89
434。67
4■9.89
4■6.67
■■■
Perception of Isomet,ric Performance for the
Exercised Leg
Entttre populattton
Group  contro■
Day 2
Day 3
Day 4
Day 5
Group Treatment
Day 2
Day 3
Day 4
Day 5
Population
ConErol
Percept,ion of Eccentric Performance for the
Exercised Leg
Treatment,
Mean
3 .67
3.77
3 .40
3 .40
3 .80
4.50
3 . s5
3.22
2 .89
3 .67
4 .44
Mean
5.55
3。70
3.20
3.30
3.80
4.50
3.39
3.00
2.67
3.56
4。33
Std Dev
■。■4
■.07
0.69
■.50
■.03
0.53
■.2■
0。97
■.45
0.87
■.0■
Std Dev
■.■■
■.09
0.63
■。49
■.03
0.53
■。■3
0。50
■.■2
0.88
■。22
Ent.ire
GrouP I
Day 2
Day 3
Day 4
Day 5
Group
Day 2
Day 3
Day 4
Day 5
|~
■■2
Perception of Isometric
NonexerciSed Leg
Entire popu■ation
Group  control
Day 2
Day 3
Day 4
Day 5
Group Treatment
Day 2
Day 3
Day 4
Day 5
Percepttton of Eccentr■c
Nonexerc■sed Leg
Ent,ire Population
Group Control
Day 2
Day 3
Day 4
Day 5
Group TreatmenE
Day 2
Day 3
Day 4
Day 5
Performance fo  the
Performance
Mean
4.20
4.22
4 .00
4.20
4.30
4 .40
4.t7
4 .00
4.00
4.tt
4.56
for the
Std Dev
O.75
0。70
0。47
0。92
0。67
0。70
0.8■
0.50
0。87
0。93
0.88
Mean
4.L3
4.1,7
3 .80
4.20
4.30
4 .40
4.08
4 .00
4 .00
3 .89
4 .44
Std Dev
O.79
0。7■
0。42
0。92
0.67
0。70
0.87
0.50
0.87
■。■7
0。88
■■3
Pain Scale Responses
Entire Popu■ation
Group  contro■
Day 2
Day 3
Day 4
Day 5
Group Treatment
Day 2
Day 3
Day 4
Day 5
for the Exerc■sed Leg
Mean         std Dev
■.63           ■.20
■.44           ■.■8
2.02           ■.o9
■。90           ■。45
■.34           0。93
0.50          0。47
■.84           ■.20
■.9■           0。88
2.82           ■.24
■.76            ■.■3
0。89           0。79
Pattn Sca■e RespOnses for the Nonexercised Leg
Mean         Std DeV
Entire Population          O.67           0。68
Group  Contro■      ,      0。73         0。76
Day 2                    0。90     0。82
Day 3                    0.94           ■.05
Day 4                    0。80      0.59
Day 5             .      0.28           0.29
Ai2pendix G
Raw Data
Below is a key to the raw data table that is on thefollowing pages:
subj ect = subj ect nurnlcergrouP=liscontrol
2 is treatment,
day = gest day
Actual Performance
v1 = exercised 1eg isomet,ric hamstring
v2 = €x€rcised Ieg isometric quadricep
v3 = exercised leg eccentric hamstring
v4 = exercised 1eg eccentric quadricep
v5 = rron€x€rcised 1eg isometric hamstring
v5 = frorr€x€rcised 1eg isometric guadricep
v7 = nonexercised 1eg eccent,ric hamstring
vB = nonexercised Ieg eccentric guadricep
Perception of Performance
p1 = exercised 1eg isometric hamstringp2 = exercised leg isometrj-c guadricepp3 = exercised Ieg eccentric hamstringp! = exercised Ieg eccentric quadricepp5 = nonexercised 1eg isometric hamstringp5 = nonexercised 1eg isometric quadricepp7 = nonexercised leg eccentric hamstringp8 = florlex€rcised 1eg eccentric guadricep
Pain Scale Responses
painL = exercised legpain2 = rlorleX€rcised Ieg
■■4
l15
subigroup v2 v4 v6 D2 p4 pain 1 pa:n2
1 1 1 308 526 372498 56626294581
1 1 2 251671238572292775 362 4 4 4 4 4 4 0
1 1 3 173 491289584 6003445712 3 3 4 4 4 4 22 02
1 1 4 242 7023 4654225599 5164 4 4 4 4 4 4 4 04 ‐04
1 1 5 218719270602246665 5894 4 4 4 4 4 4 4 0
2 1 1 264685286580284761293580
1 208680 25274257 740265539 4 4 4 4 4 4 4 26 16
2 1 265 745280525305633309484 5 5 02
4 247 716247 514297703283 475 2 4 4 4 4
2 1 294748297589 3295404 4 4 4 4 4 4 04
3 1 1 258450 255471246 263
1 2 241578269482264508244457 3 3 4 4 4 4 16
3 1 278 452225 485247 439 2 2 16
3 1 4 254527253500277678 270 5 5 5 12 08
232 250451 552279 497 5 5 5
4 1 1 264408 434210 340
4 1 2 140390 106 546 412 3 46
4 1 3 35363 335 146432 3472 4 56 14
4 1 4 39462349 196494182 5 5
4 1 463126 4851903665 6 66 6 14 08
5 1 1 136355 175 143225127
5 1 159 125214 229 3 4 4 26
134369 12713126247116263 5 14 14
1 4 132310 253 16
1 354 133256147374 125 5 5 5 0
6 1 226605 25722 262549294 458
6 1 520 424273525 226496 3 4 4 4 4 14
1 636 229 41640246474 2 4 4 4 4 02
6 1 4 298680225449286683 24253 3 4 4 4 4 08
1 308615 246 465307 686 260478 4 4 4 4 4 4 4 04
1 1 195 194 431 492156375
1 224 4972153801844841864044 4 4 4 4 4 12 04
1 242496221411218 494190322 3 3 34
7 1 4 224459222340201537 4053 3 3 1.2 06
7 1 567 239406 519 2093464 4 4 4 4 4 44 02
8 1 1 272600 42041474270 417
8 1 269619 270419 2644984 4 4 4 4 4 4 4 14
1 226 272472251 228 4 4 4 4 4 4 16 02
1 4 269616 274 4152 3 302523 4 4 4 4 4 44108
8 208647 279 442670 5474 4 4 4 4 4 4 4106
1 1 235385 234 413
1 192424209355 336 3271 3 3 4 44 4126
9 1 213 104 3081 3 4 44
419241 27945027438214 4 4 4 414 441 1
1 295 270 4892 9557306101 5 41 41 06
10 1 1 220 225447 3551
1 153 19729314 4 4 4 41 08
1 341203 284 16828316 6 66 616 6108 08
10 1 4 172435 258198 364 2032841 3 1
10 1 189432 259 1631s I 5 414 41
? ?
06 06
21 1 48353 7163446931
2 276709303566295 708296602 12 2 414 41 4134 14
1 698289 632725 63012 21 4.2 14
4 302759 355698 30064114 4 414 08
283774280509 323549 594 1 5 616 61 04
1 245 456406 404 381 1
2 383 475 401 1 3 414 41 4124 08
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subigrOuDdav v2 v4 v6 v7v8 D3p4 p5 D8painl Dain2
215447169337 223424 3 3 3 24 08
2 4 229 498 21736 1854491963234 4 4 4 4 4 16 08
2 5 247458213321237385 1903 54 4 4 4 4 4 04
293579269 422 283514 337
2 307544 277387237446269415 3 3 4 4 4 4 22 02
3 318476250 295539282 4753 3 4 4 4 4 26 02
4 307 384275448245 248 4553 3 4 4 4 4
2 5 483 2663 82454512314094 4 4 4 4 4 4 4 02
14 1 303439291408 24291269 476
14 2 276520 26639130451 2984174 4 3 3 4 4 4 4 02
14 2 279451252368266 494384 5 04
14 4 283 490263407304 259 4255 5 66 66 04
14 5 32263930441 305 4494606 6 5 56 6 0 0
2 1 414306158382176445181356
2 2215428 207352203376 3415 3 5 5 5 04
2 3 220451190 485199345 2 25
15 4 4432093982244212063295 4 4 3 06
5 200543208 475220 6 66 65 02 02
2 1 282462284463 287 525
16 2 2301557191411225512 247304 4 4 4 4 4 4 4 0
16 3 265491170 367223442192374 3 3 3
4 234460 441 194397 3 4 4 4 4 1
16 198496227393 2724182464034 4 6 6 4 4 5 0
2 1 164534 222 432380
182 166 230 234356 3 4 4 4
164325 341219 1 1 1 1 4 4 4 4 42 04
4 506 255 230346 23367 3 4 4 4 4
250613 267446 432 4454 4 44 4 4 4 4 02
2 1 260558290 477
631 300 536325 327571 3 4 4 4 4 1 0
3 276593 265436 4801 1 2 4
4 254643249 404333657 2493 8 3 4 1
264685257 422332 4 333 4 4 4 4 0
1 333651284461 618 266
2 2249 714264 387 636 24089 3 14 1
2 3 2233392417352384943 4 4 44 16
2 4309718243370 282 8002414443 3
267669274 693 4 4 4 4 14
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